Johnson & Johnson Innovation, in collaboration with the Population Health Research team at Janssen Scientific Affairs, LLC, is proud to launch the Advancing Health Equity QuickFire Challenge.
Donor Name: Johnson & Johnson Innovation
State: All States
County: All Counties
Type of the Grant: challenge
Deadline: 06/24/2022
Size of the Grant: $400,000
Details:
Innovators are invited to submit potentially ground-breaking solutions that could advance the trajectory of population health research from basic detection to the design and implementation of interventions aiming to reduce healthcare inequities.
What they’re looking for
They encourage US-based innovators to submit potentially groundbreaking solutions that could advance the trajectory of population health research from basic detection to the design and implementation of interventions aiming to reduce healthcare inequities. They are interested in potential solutions aligned to the areas of strategic focus and expertise in Oncology of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), specifically:
- Lung cancer
- Multiple myeloma
- Prostate cancer
Funding Information
- Grant funding from a total pool of $400,000.
Eligibility Criteria
They are seeking potential solutions aiming to reduce health inequities for communities that have been historically marginalized, utilizing criteria such as:
- Developing appropriate intervention strategies, especially in community-based settings
- Evaluating the performance of an intervention with appropriate evaluation techniques, and
- Determining if a strategy for advancing health equity is ready for implementation and translation/scaling into routine care settings.
For more information, visit Advancing Health Equity QuickFire Challenge.
